Home / Clinical Research / Arthrohills Capsule
Joint Support

Arthrohills Capsule

Herbal Hills® brand formulation · Joint Support · clinical study summary

Source: CTRI/2017/06/008786; IJRAMS 2021Updated 28 October 2026

Arthrohills Capsule is a Herbal Hills joint care formulation made by the Siddha Ghruta method. It has been evaluated in a CTRI-registered 90-day open-label study in 33 adults and in a 21-day safety and tolerability study in 30 adults, published in the International Journal of Research in Ayurveda and Medical Sciences (2021).

Herbal Hills® brand product
Arthrohills Capsule
30 soft gelatin capsules · available for private label
Brand reference
Herbal Hills® · Isha Agro Developers Pvt Ltd
Study published in
CTRI/2017/06/008786; IJRAMS 2021

Study at a Glance

Clinical study on the Herbal Hills® Arthrohills Capsule formulation

FieldStudy A (Registered Trial)Study B (Published Safety Study)
Study titleAn Open Label, Prospective, Multicentre, Clinical study to evaluate efficacy and safety of Arthrohills Capsules in subjects suffering from Osteoarthritis of Knee(s)A Safety Evaluation and Tolerability of Arthohills Capsule an Ayurveda Formulation in Osteoarthritis Subjects
Registration / journalCTRI/2017/06/008786, registered 08/06/2017Int J Res Ayurveda Med Sci 2021; 4(1): 22–27 (ISSN 2582-2748)
DesignOpen-label, prospective, single-arm; IEC approvedObservational, non-comparative, prospective; IEC approved, ICMR guidelines
Participants33 adults with mild to moderate knee osteoarthritis30 adults aged 40–70 with knee osteoarthritis
Dose and duration2 capsules daily, morning, empty stomach, with lukewarm water or milk; 90 days2 capsules (500 mg) twice a day; 21 days
MeasuresVAS pain, WOMAC, time to walk 50 feet, quality of life, global evaluation, adverse events, lab testsVAS pain, WOMAC (pain, stiffness, physical function), haematology, knee X-ray, adverse events
SponsorHerbal Hills (Isha Agro Developers Pvt Ltd)Herbal Hills; conducted at Vishwanand Kendra, Pune

Composition

Each soft gel capsule contains Arthrohills Ghruta 500 mg, processed by the Siddha Ghruta method with cow ghee and cow milk and the following herbs (as published):

IngredientBotanical NamePartQuantity
SuntheeZingiber officinaleRhizome22.75 mg
ShallakiBoswellia serrataGum resin45.45 mg
Shuddha GuggulBalsamodendron mukulGum resin45.45 mg
Shuddha LakshaLaccifer laccaResin45.45 mg
NirgundeeVitex negundoWhole plant45.45 mg
MethiTrigonella foenum-graecumSeeds45.45 mg
AsthishrunkhalaVitis quadrangularisStem45.45 mg
MaharasnadiGeneric preparation—90.90 mg
DashmooladiGeneric preparation—90.90 mg
ChopchineeRheum emodiRoot22.75 mg
Go Ghrit / Go DugdhaCow ghee / cow milk—Processing base

Key Results

MeasureBaselineEnd of StudyChange
Study A: VAS pain score (mean ± SD)68.93 ± 15.4031.88 ± 14.47 (day 90)−53.7%, p<0.05
Study A: WOMAC pain score——−48.84%
Study A: WOMAC stiffness score——−53.95%
Study A: investigator global assessment——81.81% showed minimum to much improvement
Study A: needed paracetamol for pain——6.06% of participants
Study B: VAS pain score40.28 ± 4.7823.78 ± 2.01 (day 21)−41.0%, p<0.001
Study B: WOMAC total48.2127.12−43.7%, p<0.001
Study B: WOMAC pain sub-score10.224.11−59.8%
Study B: WOMAC stiffness sub-score3.051.03−66.2%
Study B: WOMAC physical function34.1121.67−36.5%

In Study A, mean knee pain on the VAS fell steadily at every 15-day visit, from 68.93 at baseline to 31.88 at day 90. In Study B, VAS pain fell from 40.28 to 23.78 over 21 days, and every WOMAC sub-score improved significantly (p<0.001). Percentages in the table are calculated from the published means.

SafetyIn Study B, all 30 participants completed the study, blood tests and knee X-rays at day 21 stayed within normal limits and comparable with baseline, and no adverse drug reactions were recorded. The Study A summary reports that the formulation was well tolerated and that most adverse events recorded were not related to the study product.
Study LimitationsNeither study had a placebo or comparator group, both were sponsor-funded, and sample sizes were small (30–33). Study B lasted only 21 days. The results describe what happened in these study groups and are not a guarantee of results for every user.

Private Label Availability

The Herbal Hills® Arthrohills Capsule formulation is available for private label and third party manufacturing at Herbal Hills, Lonavala. The study above was conducted on the Herbal Hills® Arthrohills Capsule and supports the formulation only; a product launched under your brand name is subject to its own licences and approvals.

ⓘ Regulatory note: The clinical studies on this page were conducted on Herbal Hills® brand formulations under their original Herbal Hills product names. They are shown only as supporting evidence for the formulation. A product launched under a different brand name is not, by that fact, an independently tested product, and these studies may not be used in that brand’s labelling or advertising without the required regulatory approvals. Formulations may be developed or launched for private label partners subject to the applicable licences, product applications and approvals. This page is intended for business buyers and healthcare professionals; it does not claim that any product diagnoses, treats, cures or prevents any disease, and individual results vary.
— Evaluate before you decide

Ask for a FREE trial sample

Get a trial sample with the full study document and product specifications. Email business@herbalhills.in or use the enquiry form.

Study ReferenceStudy A: CTRI/2017/06/008786 (registered 08/06/2017), Clinical Trials Registry – India. Study B: Mandlecha A, Mujawar G. A Safety Evaluation and Tolerability of Arthohills Capsule an Ayurveda Formulation in Osteoarthritis Subjects. Int J Res Ayurveda Med Sci 2021; 4(1): 22–27.
Download this study summary
Share it with your team or regulatory reviewer.
↓ Download PDF
« All clinically studied formulations